Creating Confidence in Commercial Assessments for Rare Disease Drugs We support commercial leaders who are entrusted with the important responsibility to shepherd valuable rare disease drug candidates through clinical development and to a successful launch or transaction.Sentero Pharma specializes in establishing the commercial potential for development-stage rare disease drugs.Whether a capital raise, M&A transaction or commercial launch is planned, going beyond the 30K' view is meticulous work, and requires time and focus.Sentero's 1K'VIEW(TM) commercial assessment helps you methodically build and confidently articulate your value story with the right data, the best insights and a clear-eyed view on:- Competition- Market Size & Structure- Access & Pricing- Market Share & Forecast- SG&A PlanningWe know the weight of your responsibilities to help fulfill the promise for patients and the high expectations of your company's stakeholders.Expectations get set early. Let's get it right.